| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| L-亮氨酸; L-Leucine | CFN94811 | 61-90-5 | C6H13NO2 = 131.2 | 20mg | QQ客服：3257982914 |
| 罗丹明 B; Rhodamine B | CFN96910 | 81-88-9 | C28H31ClN2O3 = 479.01 | 20mg | QQ客服：215959384 |
| 烟曲酶毒素 C ; Fumitremorgin C | CFN96930 | 118974-02-0 | C22H25N3O3 = 379.46 | 5mg | QQ客服：1413575084 |
| Demethoxyfumitremorgin C; Demethoxyfumitremorgin C | CFN96937 | 111768-16-2 | C21H23N3O2 = 349.43 | 5mg | QQ客服：2056216494 |
| Pseurotin A ; Pseurotin A | CFN96943 | 58523-30-1 | C22H25NO8 = 431.44 | 5mg | QQ客服：3257982914 |
| 三聚氰胺 ; Melamine | CFN96945 | 108-78-1 | C3H6N6 = 126.12 | 20mg | QQ客服：1413575084 |
| 14-Norpseurotin A; 14-Norpseurotin A | CFN96959 | 1031727-34-0 | C21H23NO8 = 417.41 | 5mg | QQ客服：1457312923 |
| FD-838 ; FD-838 | CFN96970 | 110341-78-1 | C22H21NO7 = 411.41 | 5mg | QQ客服：1413575084 |
| 1,7-Dihydroxyacridone; 1,7-Dihydroxyacridone | CFN96973 | 112649-95-3 | C13H9NO3 = 227.21 | 5mg | QQ客服：3257982914 |
| Emeheterone; Emeheterone | CFN96983 | 117333-12-7 | C19H18N2O3 = 322.36 | 5mg | QQ客服：2159513211 |
| 粉蕊黄杨胺 M; Pachysamine M | CFN89007 | 1253202-75-3 | C28H44N2O2 = 440.67 | 5mg | QQ客服：2056216494 |
| 烟曲酶毒素 B; Fumitremorgin B | CFN89011 | 12626-17-4 | C27H33N3O5 = 479.57 | 5mg | QQ客服：2056216494 |
| 3,6-Dibenzyl-2-hydroxy-5-methoxypyrazine; 3,6-Dibenzyl-2-hydroxy-5-methoxypyrazine | CFN89034 | 132213-65-1 | C19H18N2O2 = 306.36 | 5mg | QQ客服：1457312923 |
| 腺嘌呤; Adenine | CFN89041 | 73-24-5 | C5H5N5 = 135.13 | 20mg | QQ客服：2056216494 |
| Brevianamide F ; Brevianamide F | CFN89048 | 38136-70-8 | C16H17N3O2 = 283.33 | 10mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)